Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-19, Stock:LLY, The news for the past five days is as follows:
2019-07-12: NEWS1: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS2: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS3: S&P 500 Movers: ILMN, JBHT.NEWS4: S&P 500 Movers: ILMN, JBHT.NEWS5: Drug Pricing Woes Linger on Repealing Drug Rebate Proposal.NEWS6: Health Care stocks help lead Wall Street rally.NEWS7: Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug.NEWS8: Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine.NEWS9: AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine.
2019-07-15: nan
2019-07-16: NEWS1: Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA.NEWS2: Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet.NEWS3: Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA.NEWS4: Jim Cramer Weighs In On Marvell, General Motors And More.
2019-07-17: NEWS1: IWV, LLY, BKNG, MDLZ: Large Outflows Detected at ETF.NEWS2: IWV, LLY, BKNG, MDLZ: Large Outflows Detected at ETF.NEWS3: AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease.
2019-07-18: NEWS1: 2 Small-Cap Biotech IPOs You Should Know About.NEWS2: 2 Small-Cap Biotech IPOs You Should Know About.NEWS3: NuCana Initiates Dosing in Phase I Study for Solid Tumors.NEWS4: NuCana Initiates Dosing in Phase I Study for Solid Tumors.NEWS5: AC Immune Initiates Phase I Study for Alzheimer's Disease.NEWS6: AC Immune Initiates Phase I Study for Alzheimer's Disease.NEWS7: NuCana Initiates Dosing in Phase I Study for Solid Tumors.NEWS8: AC Immune Initiates Phase I Study for Alzheimer's Disease.

Answer: Decrease